Researchers already knew that men and postmenopausal women
have a higher risk of developing Parkinson's disease than premenopausal women.
Now, a recent study in mice concludes that estrogen may be responsible. The
authors also hope that estrogen might form the basis of future treatments.
Parkinson's disease is a
neurodegenerative condition. According to the National Institutes of Health
(NIH), about 50,000 people in the United States receive a
diagnosis of Parkinson's every year.
Today,
approximately 500,000 people in the U.S. are living with Parkinson's disease.
One
of the primary risk factors is advanced age, so as the population grows ever
older, the number of Parkinson's cases is likely to rise.
Understanding
how and why the condition develops is paramount because there is currently no
cure.
Alpha-synuclein and Parkinson's
The
primary driver of Parkinson's is a mutated, shorter-than-normal version of a
protein called alpha-synuclein.
This
protein congregates inside the dopamine-producing neurons that are responsible
for coordinating movements and forms structures called Lewy bodies and
neurites.
Over
time, the buildup of alpha-synuclein prevents brain cells from functioning and,
eventually, they die. The resultant loss of neurons causes the movement
problems that are characteristic of Parkinson's, such as tremor and rigidity.
Although
scientists have been studying Parkinson's for decades, there are still many
gaps in their knowledge.
One
of these unanswered questions is why Parkinson's occurs earlier in men and is
more common in postmenopausal women.
Recently,
a group of researchers from Harvard Medical School in Boston, MA, decided to
take a close look at the role of estrogen. They published
their findings in the journal JNeurosci.
Why estrogen?
Earlier
studies identified a relationship between estrogen and Parkinson's disease.
For
instance, the authors of a 2004 study investigating
Parkinson's risk and its relationship with "reproductive
characteristics" concluded that there was "[a]n association between
factors reducing estrogen stimulation during life and [Parkinson's
disease]."
Other
findings over the years have hinted that estrogen might protect the brain.
One studyrecruited
women who had undergone an oophorectomy, which is the surgical removal of one
or both ovaries, the primary source of estrogen in women.
They found
that these women had an increased risk of cognitive decline and Parkinson's
disease.
Other
studies have found evidence that estrogen might help reduce symptoms of
Parkinson's. One small-scale study,
for example, found that low doses of estrogen reduced motor symptoms in
postmenopausal women with Parkinson's.
Although
estrogen's neuroprotective powers are becoming better established, exactly how
estrogen might protect against Parkinson's disease is still a mystery.
Source: Medical News Today
No comments:
Post a Comment